BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25888902)

  • 21. Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma.
    Kimura K; Amano R; Nakata B; Yamazoe S; Hirata K; Murata A; Miura K; Nishio K; Hirakawa T; Ohira M; Hirakawa K
    World J Surg Oncol; 2014 Nov; 12():360. PubMed ID: 25429841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediastinal downstaging after induction treatment is not a significant prognostic factor to select patients who would benefit from surgery: the clinical value of the lymph node ratio.
    Renaud S; Falcoz PE; Olland A; Reeb J; Santelmo N; Massard G
    Interact Cardiovasc Thorac Surg; 2015 Feb; 20(2):222-7. PubMed ID: 25413781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The validity of predicting prognosis by the lymph node ratio in node-positive colon cancer.
    Sugimoto K; Sakamoto K; Tomiki Y; Goto M; Kojima Y; Komiyama H
    Dig Surg; 2013; 30(4-6):368-74. PubMed ID: 24107470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].
    Zhu XW; Wu CS; Yuan SC
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy.
    Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Shiozawa M; Kobayashi S; Ueno M; Morimoto M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
    Anticancer Res; 2018 Aug; 38(8):4877-4882. PubMed ID: 30061263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma.
    Grotz TE; Huebner M; Pockaj BA; Perkins S; Jakub JW
    Ann Surg Oncol; 2013 Dec; 20(13):4370-7. PubMed ID: 24046102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
    Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
    World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical impact of the lymph node ratio as a prognostic factor after resection of pancreatic cancer.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2014 May; 34(5):2389-94. PubMed ID: 24778048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
    Solak M; Turkoz FP; Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Sever AR; Altundag K
    J BUON; 2015; 20(3):737-45. PubMed ID: 26214625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The lymph node ratio as a prognostic factor for gastric cancer.
    Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K
    Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.
    Min JS; Jin SH; Park S; Kim SB; Bang HY; Lee JI
    Ann Surg Oncol; 2012 Feb; 19(2):494-501. PubMed ID: 21837527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse oncologic effects of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy.
    Hwang HK; Jung MJ; Lee SH; Kang CM; Lee WJ
    J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):497-507. PubMed ID: 27295957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-related changes in the prognostic significance of the total number of examined lymph nodes in node-negative pancreatic head cancer.
    Gleisner AL; Spolverato G; Ejaz A; Pawlik TM
    J Surg Oncol; 2014 Dec; 110(7):858-63. PubMed ID: 24975984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival.
    John BJ; Naik P; Ironside A; Davidson BR; Fusai G; Gillmore R; Watkins J; Rahman SH
    HPB (Oxford); 2013 Sep; 15(9):674-80. PubMed ID: 23458477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database.
    Schwarz RE; Smith DD
    Ann Surg Oncol; 2006 Sep; 13(9):1189-200. PubMed ID: 16955385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic adenocarcinoma: number of positive nodes allows to distinguish several N categories.
    Strobel O; Hinz U; Gluth A; Hank T; Hackert T; Bergmann F; Werner J; Büchler MW
    Ann Surg; 2015 May; 261(5):961-9. PubMed ID: 24979603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.